Dermatology focuses on the health of the skin, hair, and nails. Learn about the diagnosis and treatment of acne, eczema, skin cancer, and cosmetic procedures.
Send us all your questions or requests, and our expert team will assist you.
Diagnosis and evaluation of eczema is a critical first step toward effective, long‑term skin health, especially for international patients seeking specialist care. At Liv Hospital, our dermatology team follows a systematic, evidence‑based approach that combines detailed patient interviews, state‑of‑the‑art testing, and personalized interpretation of results. According to recent dermatologic surveys, up to 30 % of individuals with chronic eczema experience delayed or inaccurate diagnosis, leading to prolonged discomfort and unnecessary treatments. This page guides you through each stage of the diagnostic journey, from initial presentation to ongoing monitoring, ensuring you understand what to expect during your visit to our Istanbul clinic.
Whether you are newly diagnosed, experiencing a flare‑up, or looking for a second opinion, the information below will help you prepare for appointments, understand the purpose of each test, and collaborate effectively with our multidisciplinary team. Our goal is to provide transparent, compassionate care that respects the unique medical histories of patients from around the world.
Eczema, medically known as atopic dermatitis, is a chronic inflammatory skin condition characterized by intense itching, redness, and scaling. While the exact cause remains multifactorial, genetic predisposition, immune system dysregulation, and environmental triggers such as allergens, temperature changes, and stress play pivotal roles.
Typical clinical signs include:
Recognizing these patterns helps clinicians narrow the diagnostic focus early in the diagnosis and evaluation process. Our dermatologists also assess for secondary infections, which can complicate the picture and require targeted antimicrobial therapy.
The first encounter centers on a thorough medical interview and physical examination. Detailed history gathering allows us to identify potential triggers, comorbidities, and the disease’s impact on daily life.
Key elements of the assessment include:
History Component | Why It Matters |
|---|---|
Onset Age | Early childhood onset suggests atopic background. |
Family History | Genetic predisposition increases risk. |
Allergy Exposure | Identifies environmental or food allergens. |
Previous Treatments | Helps avoid ineffective or contraindicated therapies. |
Quality‑of‑Life Impact | Guides the urgency and intensity of management. |
During the physical exam, clinicians document lesion distribution, severity scoring (e.g., SCORAD), and signs of infection. This comprehensive snapshot forms the backbone of the diagnosis and evaluation workflow and informs subsequent testing decisions.
While eczema is primarily a clinical diagnosis, laboratory tests can clarify atypical presentations, rule out mimicking conditions, and detect associated atopic disorders such as asthma or allergic rhinitis.
Common investigations include:
Our laboratory follows international standards, ensuring rapid turnaround and accurate results. The data gathered are integrated into the overall diagnosis and evaluation report, allowing the care team to tailor therapy precisely to each patient’s profile.
Advanced imaging is rarely required for typical eczema but becomes valuable when differentiating from other dermatoses or assessing complications such as deep skin infections.
Specialized tools employed at Liv Hospital include:
These technologies enhance the precision of the diagnosis and evaluation process, especially for patients with atypical lesions or those who have not responded to standard treatments.
Accurate differentiation prevents mismanagement. Common conditions that mimic eczema include:
Condition | Key Distinguishing Features |
|---|---|
Psoriasis | Well‑demarcated plaques with silvery scale; often on scalp and extensor surfaces. |
Contact Dermatitis | Localized to areas of direct contact with irritants or allergens; positive patch test. |
Seborrheic Dermatitis | Greasy, yellowish scales on scalp, eyebrows, and nasolabial folds. |
Scabies | Intense nocturnal itching; burrows visible on skin surface. |
Ichthyosis | Generalized dry, scaly skin from birth; genetic origin. |
Through careful history, physical examination, and targeted testing, our specialists narrow the possibilities and confirm that eczema is indeed the primary diagnosis. This rigorous diagnosis and evaluation safeguards patients from unnecessary medication and directs them toward effective, evidence‑based therapies.
Once all data are collected, the multidisciplinary team synthesizes findings to create a customized management strategy. Core components typically include:
Our approach emphasizes shared decision‑making, ensuring patients understand the rationale behind each recommendation. The comprehensive diagnosis and evaluation report is shared with the patient and, when requested, with their home‑country physicians to maintain continuity of care.
Eczema often requires long‑term management, making regular follow‑up essential. Monitoring focuses on treatment efficacy, side‑effect surveillance, and adjustment of therapeutic goals.
Typical follow‑up schedule:
During each visit, clinicians reassess disease severity using standardized scores, repeat relevant laboratory tests if needed, and reinforce education on lifestyle modifications. This continuous loop of assessment, treatment, and re‑evaluation embodies the essence of effective diagnosis and evaluation for eczema.
Liv Hospital offers JCI‑accredited dermatology services with a dedicated international patient program. Our Istanbul facility combines cutting‑edge technology, multilingual staff, and seamless coordination of appointments, transportation, and accommodation. Patients receive personalized care from board‑certified dermatologists experienced in complex eczema cases, ensuring a trustworthy and comfortable experience from the moment you arrive.
Ready to take the next step toward clearer, healthier skin? Contact Liv Hospital today to schedule your comprehensive eczema diagnosis and evaluation. Our international patient team will guide you through every detail, ensuring a smooth and supportive journey.
Liv Hospital Ulus
Asst. Prof. MD. Ayşe Deniz Akkaya
Dermatology
Liv Hospital Ulus
Asst. Prof. MD. Nazlı Caf
Dermatology
Liv Hospital Ulus
Prof. MD. İlteriş Oğuz
Dermatology
Liv Hospital Ulus
Spec. MD. Ömer Gezdur
Dermatology
Liv Hospital Vadistanbul
Assoc. Prof. MD. Ece Altun
Dermatology
Liv Hospital Vadistanbul
Prof. MD. Sevilay Oğuz Kılıç
Dermatology
Liv Hospital Vadistanbul
Spec. MD. Marziyeh Javadpour
Dermatology
Liv Hospital Vadistanbul
Spec. MD. Meryem Ayşit
Dermatology
Liv Hospital Bahçeşehir
Assoc. Prof. MD. Nadir Göksügür
Dermatology
Liv Hospital Bahçeşehir
Spec. MD. Esengül Kaya
Dermatology
Liv Hospital Bahçeşehir
Spec. MD. Vedat Ertunç
Dermatology
Liv Hospital Bahçeşehir
Spec. MD. Özlem İpek
Dermatology
Liv Hospital Topkapı
Spec. MD. Betül Kızılkan
Dermatology
Liv Hospital Topkapı
Spec. MD. Gizem Gökçedağ Ünsal
Dermatology
Liv Hospital Ankara
Asst. Prof. MD. Caner Demircan
Dermatology
Liv Hospital Ankara
Spec. MD. Aylin Gözübüyükoğulları
Dermatology
Liv Hospital Ankara
Spec. MD. Elçin Akdaş
Dermatology
Liv Hospital Ankara
Spec. MD. Vahid Ahmadi
Dermatology
Liv Hospital Gaziantep
Spec. MD. Hatice Kübra Çakı
Dermatology
Liv Hospital Samsun
Asst. Prof. MD. Gül Şekerlisoy Tatar
Dermatology
Liv Hospital Samsun
Spec. MD. Ayşe İdil Baş
Dermatology
Liv Bona Dea Hospital Bakü
Spec. MD. İRFAN QEHREMANOV
Dermatology
Asst. Prof. MD. A. Deniz Akkaya
Dermatology
MD. Gül Şekerlisoy Tatar
Dermatology
Send us all your questions or requests, and our expert team will assist you.
At Liv Hospital, the first step is a thorough patient history to identify triggers, family history, and previous treatments. A physical examination documents lesion distribution and severity using scores like SCORAD. Depending on the presentation, clinicians may order serum IgE, CBC, skin patch testing, or cultures. Advanced tools such as dermatoscopy or high‑resolution ultrasound are used for atypical cases. All findings are compiled into a comprehensive diagnosis report that guides personalized therapy.
While eczema is primarily diagnosed clinically, labs help clarify atypical cases. Serum IgE levels often rise in atopic patients. A CBC can reveal eosinophilia or infection. Patch testing identifies contact allergens that may worsen eczema. Swab cultures are taken when secondary bacterial infection is suspected. In severe, refractory cases, genetic testing for filaggrin mutations may be offered to understand disease severity and guide treatment.
Differentiation relies on distinct clinical features: eczema shows ill‑defined, itchy, lichenified patches, while psoriasis presents well‑demarcated plaques with silvery scale. Dermatoscopy helps visualize surface patterns that separate the two. Patch testing can confirm contact dermatitis, and a skin biopsy may be performed if the diagnosis remains uncertain. The multidisciplinary team reviews all data to ensure the correct diagnosis and avoid inappropriate therapy.
Treatment is tailored to disease severity. Mild cases often respond to emollients and low‑potency topical steroids. Moderate‑to‑severe disease may require prescription‑strength steroids, calcineurin inhibitors, or systemic biologics such as dupilumab. Adjuncts include bleach baths for bacterial colonization, phototherapy, and targeted moisturizers. If patch testing identifies specific allergens, avoidance strategies are incorporated. Education on trigger identification and proper skin‑care routines is a core component of the plan.
Follow‑up timing is individualized. After the first treatment course, patients are seen within 2–4 weeks to assess response and adjust therapy. Stable patients typically return every three months for routine monitoring of disease activity, side‑effects, and lab parameters. Additional appointments are arranged promptly if a flare occurs, new systemic medication is introduced, or if there are concerns about treatment tolerance.
Genetic testing is optional and usually reserved for patients with early‑onset, severe eczema unresponsive to standard therapies. Mutations in the filaggrin (FLG) gene compromise skin barrier function, leading to higher susceptibility to irritants and infections. Knowing a patient’s genetic status can prompt more aggressive barrier‑repair strategies, early use of systemic agents, and closer monitoring, ultimately improving long‑term outcomes.
Dermatoscopy provides magnified visualization of surface patterns, helping distinguish eczema from psoriasis or fungal infections. High‑resolution ultrasound measures skin thickness and detects subclinical edema, useful in chronic or complicated cases. Confocal laser scanning microscopy offers cellular‑level imaging for research‑oriented or refractory cases, allowing clinicians to observe inflammatory infiltrates and barrier defects without invasive biopsies.
BlogDermatologyApr 08, 2026Stasis dermatitis, also known as varicose eczema, affects millions over 50. Discover the 5 stages, warning ...
BlogDermatologyApr 01, 2026Relieve rash under stomach fold with proven OTC treatments & home remedies from Liv Hospital.
BlogDermatologyMar 25, 2026Experiencing scalp pain when touched? Discover 7 quick solutions to relieve scalp tenderness and regain com...
BlogDermatologyMar 25, 2026Struggling with itchy legs at night? Liv Hospital's multidisciplinary experts provide fast relief for Restl...
BlogDermatologyMar 24, 2026As we get older, our skin changes a lot. It loses collagen and gets wrinkles. Many people in their 60s and ...
BlogDermatologyMar 24, 2026Millions worldwide deal with discolored skin from sunburn. UV rays can cause lasting damage, dark spots, an...
Get instant answers from our medical team. No forms, no waiting — just tap below to start chatting now.
Start Chat on WhatsApp or call us at +90 530 174 28 17